Literature DB >> 29417941

CTC clusters induced by heparanase enhance breast cancer metastasis.

Rong-Rui Wei1, Dan-Ni Sun2, Hong Yang2, Juan Yan2, Xiong Zhang2, Xing-Ling Zheng2, Xu-Hong Fu2, Mei-Yu Geng2, Xun Huang3, Jian Ding4.   

Abstract

Aggregated metastatic cancer cells, referred to as circulating tumor cell (CTC) clusters, are present in the blood of cancer patients and contribute to cancer metastasis. However, the origin of CTC clusters, especially intravascular aggregates, remains unknown. Here, we employ suspension culture methods to mimic CTC cluster formation in the circulation of breast cancer patients. CTC clusters generated using these methods exhibited an increased metastatic potential that was defined by the overexpression of heparanase (HPSE). Heparanase induced FAK- and ICAM-1-dependent cell adhesion, which promoted intravascular cell aggregation. Moreover, knockdown of heparanase or inhibition of its activity with JG6, a heparanase inhibitor, was sufficient to block the formation of cell clusters and suppress breast cancer metastasis. Our data reveal that heparanase-mediated cell adhesion is critical for metastasis mediated by intravascular CTC clusters. We also suggest that targeting the function of heparanase in cancer cell dissemination might limit metastatic progression.

Entities:  

Keywords:  CTC clusters; adhesion molecules; cell adhesion; heparanase; human breast cancer; metastasis; suspension culture method

Mesh:

Substances:

Year:  2018        PMID: 29417941      PMCID: PMC6289387          DOI: 10.1038/aps.2017.189

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  37 in total

1.  Defining the roles of beta-catenin and plakoglobin in cell-cell adhesion: isolation of beta-catenin/plakoglobin-deficient F9 cells.

Authors:  Yoshitaka Fukunaga; Huijie Liu; Masayuki Shimizu; Satoshi Komiya; Michio Kawasuji; Akira Nagafuchi
Journal:  Cell Struct Funct       Date:  2005       Impact factor: 2.212

2.  Marine-derived oligosaccharide sulfate (JG3) suppresses heparanase-driven cell adhesion events in heparanase over-expressing CHO-K1 cells.

Authors:  Qiu-Ning Li; Hai-Ying Liu; Xian-Liang Xin; Qiu-Ming Pan; Lu Wang; Jing Zhang; Qin Chen; Mei-Yu Geng; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2009-06-22       Impact factor: 6.150

3.  Circulating tumor cell analysis in metastatic triple-negative breast cancers.

Authors:  Mark Jesus M Magbanua; Lisa A Carey; Amy DeLuca; Jimmy Hwang; Janet H Scott; Mothaffar F Rimawi; Erica L Mayer; P Kelly Marcom; Minetta C Liu; Francisco J Esteva; John W Park; Hope S Rugo
Journal:  Clin Cancer Res       Date:  2014-12-18       Impact factor: 12.531

Review 4.  Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.

Authors:  Neta Ilan; Michael Elkin; Israel Vlodavsky
Journal:  Int J Biochem Cell Biol       Date:  2006-07-06       Impact factor: 5.085

Review 5.  Circulating tumor cell clusters-associated gene plakoglobin and breast cancer survival.

Authors:  Lingeng Lu; Hongmei Zeng; Xinsheng Gu; Wenxue Ma
Journal:  Breast Cancer Res Treat       Date:  2015-05-10       Impact factor: 4.872

6.  Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.

Authors:  Zhaomei Mu; Chun Wang; Zhong Ye; Laura Austin; Jesse Civan; Terry Hyslop; Juan P Palazzo; Rebecca Jaslow; Bingshan Li; Ronald E Myers; Juntao Jiang; Jinliang Xing; Hushan Yang; Massimo Cristofanilli
Journal:  Breast Cancer Res Treat       Date:  2015-11-16       Impact factor: 4.872

7.  Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease.

Authors:  G J Gasic; T B Gasic; N Galanti; T Johnson; S Murphy
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

8.  Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence.

Authors:  Chun-Jen Liu; Juliana Chang; Po-Huang Lee; Deng-Yn Lin; Cheng-Chung Wu; Long-Bin Jeng; Yih-Jyh Lin; King-Tong Mok; Wei-Chen Lee; Hong-Zen Yeh; Ming-Chih Ho; Sheng-Shun Yang; Mei-Due Yang; Ming-Chin Yu; Rey-Heng Hu; Cheng-Yuan Peng; Kuan-Lang Lai; Stanley Shi-Chung Chang; Pei-Jer Chen
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

9.  Urokinase exerts antimetastatic effects by dissociating clusters of circulating tumor cells.

Authors:  Jin Woo Choi; Jun Ki Kim; Yun Jung Yang; Pilhan Kim; Kwon-Ha Yoon; Seok Hyun Yun
Journal:  Cancer Res       Date:  2015-11-01       Impact factor: 12.701

10.  Heparanase facilitates cell adhesion and spreading by clustering of cell surface heparan sulfate proteoglycans.

Authors:  Flonia Levy-Adam; Sari Feld; Edith Suss-Toby; Israel Vlodavsky; Neta Ilan
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240

View more
  18 in total

1.  ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells.

Authors:  Ofer Regev; Marina Kizner; Francesco Roncato; Maya Dadiani; Massimo Saini; Francesc Castro-Giner; Olga Yajuk; Stav Kozlovski; Nehora Levi; Yoseph Addadi; Ofra Golani; Shifra Ben-Dor; Zvi Granot; Nicola Aceto; Ronen Alon
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

2.  Dextran sulfate prevents excess aggregation of human pluripotent stem cells in 3D culture by inhibiting ICAM1 expression coupled with down-regulating E-cadherin through activating the Wnt signaling pathway.

Authors:  Haibin Wu; Xianglian Tang; Yiyu Wang; Ning Wang; Qicong Chen; Jinghe Xie; Shoupei Liu; Zhiyong Zhong; Yaqi Qiu; Ping Situ; Mark A Zern; Jue Wang; Honglin Chen; Yuyou Duan
Journal:  Stem Cell Res Ther       Date:  2022-05-26       Impact factor: 8.079

3.  Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.

Authors:  Utsav Sharma; Kelsie Medina-Saenz; Philip C Miller; Benjamin Troness; Angela Spartz; Ana Sandoval-Leon; Deanna N Parke; Tiffany N Seagroves; Marc E Lippman; Dorraya El-Ashry
Journal:  Breast Cancer Res Treat       Date:  2021-07-03       Impact factor: 4.872

Review 4.  Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives.

Authors:  Stefania Cocco; Michela Piezzo; Alessandra Calabrese; Daniela Cianniello; Roberta Caputo; Vincenzo Di Lauro; Giuseppina Fusco; Germira di Gioia; Marina Licenziato; Michelino De Laurentiis
Journal:  Int J Mol Sci       Date:  2020-06-27       Impact factor: 5.923

Review 5.  A Review on Microdevices for Isolating Circulating Tumor Cells.

Authors:  Kin Fong Lei
Journal:  Micromachines (Basel)       Date:  2020-05-22       Impact factor: 2.891

Review 6.  Heparanase: A Challenging Cancer Drug Target.

Authors:  Deirdre R Coombe; Neha S Gandhi
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

Review 7.  Collective metastasis: coordinating the multicellular voyage.

Authors:  Emma Wrenn; Yin Huang; Kevin Cheung
Journal:  Clin Exp Metastasis       Date:  2021-07-12       Impact factor: 4.510

Review 8.  The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance.

Authors:  Hassan Dianat-Moghadam; Mehdi Azizi; Zahra Eslami-S; Luis Enrique Cortés-Hernández; Maryam Heidarifard; Mohammad Nouri; Catherine Alix-Panabières
Journal:  Cancers (Basel)       Date:  2020-04-03       Impact factor: 6.639

9.  The close relationship between heparanase and epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma.

Authors:  Shahid Shah; Caroline Fourgeaud; Simon Derieux; Shahsoltan Mirshahi; Geneviève Contant; Cynthia Pimpie; Rea Lo Dico; Jeannette Soria; Marc Pocard; Massoud Mirshahi
Journal:  Oncotarget       Date:  2018-09-18

10.  The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.

Authors:  Jian Zheng; Xiong Ye; Yanan Liu; Yuxia Zhao; Mudan He; Hui Xiao
Journal:  BMC Cancer       Date:  2020-02-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.